英文名 | 4-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]aniline |
---|---|
英文别名 |
Benzenamine, 4-[4-[2-(difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl]-
4-(4-(2-(difluoromethyl)-4-methoxy-1H-benzo[d]imidazol-1-yl)-6-morpholino-1,3,5-triazin-2-yl)aniline 4-(4-(2-(difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl)-6-(4-morpholinyl)-1,3,5-triazin-2-yl)aniline 4-{4-[2-(Difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl}aniline |
密度 | 1.5±0.1 g/cm3 |
---|---|
沸点 | 705.5±70.0 °C at 760 mmHg |
分子式 | C22H21F2N7O2 |
分子量 | 453.445 |
闪点 | 380.5±35.7 °C |
精确质量 | 453.172485 |
PSA | 104.21000 |
LogP | 2.13 |
蒸汽压 | 0.0±2.2 mmHg at 25°C |
折射率 | 1.700 |
~86% 1246203-34-8 |
文献:PATHWAY THERAPEUTICS INC.; REWCASTLE, Gordon, William; GIDDENS, Anna, Claire; GAMAGE, Swarnalatha, Akuratiya Patent: WO2012/44641 A1, 2012 ; Location in patent: Page/Page column 46; 82-84 ; WO 2012/044641 A1 |
~% 1246203-34-8 |
文献:PATHWAY THERAPEUTICS INC.; REWCASTLE, Gordon, William; GIDDENS, Anna, Claire; GAMAGE, Swarnalatha, Akuratiya Patent: WO2012/44641 A1, 2012 ; WO 2012/044641 A1 |
上游产品 2 | |
---|---|
下游产品 1 | |